BIO issued the following statement on President-elect Donald Trump’s appointment of Rep. Tom Price (R-GA) as Secretary of Health and Human Services:
BIO applauds the selection of Dr. Tom Price (R-GA) as Secretary of Health and Human Services and looks forward to working with him to ensure innovative biopharmaceutical breakthroughs are accessible to the patients that need them.
Dr. Price has been a leader in healthcare policy throughout his career in the U.S. Congress. An orthopedic surgeon by trade, the issues that doctors and patients face every day is not a hypothetical scenario for him. We’re confident that his expertise will ensure patients are put first in policy and regulatory decisions.
BIO also commends the selection of Seema Verma as Administrator of the Centers for Medicare and Medicaid Services. Ms. Verma is expert in customizing and modernizing Medicaid programs to fit specific state populations. Her wide-ranging experience in public healthcare will surely be an asset in ensuring patient focused reforms in Medicare and Medicaid.
BIO stands ready to work with the incoming Trump administration, including Dr. Price and Ms. Verma, and all other stakeholders to ensure our healthcare system allows patients to receive the best quality of care at a lower cost and access to innovative biopharmaceutical treatments and cures.